David Holtz
Direktor/Vorstandsmitglied bei DYNATRONICS CORPORATION
Vermögen: 15 507 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Stuart Essig | M | 62 | 27 Jahre | |
Brian Baker | M | 57 | 6 Jahre | |
Brian Larkin | M | 55 | 24 Jahre | |
Richard Caruso | M | 80 |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | 46 Jahre |
Erin Enright | F | 63 | 9 Jahre | |
Jeffrey Mosebrook | M | 47 | 18 Jahre | |
Gabe Ellwein | M | - | 1 Jahre | |
Sarah Rome-Mealman | F | - | 4 Jahre | |
Andrew Hulett | M | 50 | - | |
Jerry N. Holtz | M | - |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | 31 Jahre |
R. Ward | M | 68 | 11 Jahre | |
Christian Schade | M | 63 | 18 Jahre | |
Edward Staten | M | - | 5 Jahre | |
Andrea Caruso | M | - | 18 Jahre | |
Gary R. DiLella | M | - |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | - |
Michael Withers | M | 55 | 2 Jahre | |
W. Kent Silvers | M | - |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | 29 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
John Krier | M | 47 | 3 Jahre | |
Kelvyn H. Cullimore | M | 68 | 36 Jahre | |
James Norman Ogilvie | M | 38 | 5 Jahre | |
John Bostjancic | M | 53 | - | |
Richard D. Gorelick | M | 63 | 18 Jahre | |
Gerard S. Carlozzi | M | 68 | 8 Jahre | |
David Alma Wirthlin | M | 63 | 4 Jahre | |
John Henneman | M | 62 | 16 Jahre | |
Skyler Black | M | 41 | 4 Jahre | |
Neal Moszkowski | M | 58 | 14 Jahre | |
Larry K. Beardall | M | 68 | 30 Jahre | |
T. Robert Perrett | M | - | 7 Jahre | |
Cynthia L. McHenry | F | - | - | |
Christopher von Jako | M | 53 | 1 Jahre | |
Nora Brennan | F | 55 | 12 Jahre | |
Jennifer Keeler | F | 54 | 2 Jahre | |
Carol L. Amelio | F | 62 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 Jahre |
Thomas E. Gardner | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 Jahre |
Deborah A. Leonetti | F | 68 | - | |
George Murray | M | - | - | |
Howard L. Edwards | M | 92 | 18 Jahre | |
Scott Klosterman | M | 66 | 8 Jahre | |
Anne VanLent | F | 76 | 16 Jahre | |
Richard J. Linder | M | 54 | - | |
Jason C. Anderson | M | - | - | |
William Weber | M | - | - | |
Norman Roegner | M | 49 | 2 Jahre | |
David Poorvin | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 Jahre |
Michael J. Shoup | M | 63 | 1 Jahre | |
Daryl Connell | M | 52 | 2 Jahre | |
Maureen B. Bellantoni | F | 74 | 1 Jahre | |
Neil Carragher | M | 85 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 Jahre |
Thomas Jeff Gephart | M | - | 2 Jahre | |
Tyler Oglesby | M | - | 4 Jahre | |
Simon J. Archibald | M | - | 17 Jahre | |
Maria Platsis | F | - | - | |
Edward Gaj | M | 67 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 Jahre |
Karen Payne | F | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Richard W. Zahn | M | 73 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 Jahre |
David Wills | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
G. A. Fitch | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 1 Jahre |
Robert D. Paltridge | M | 66 | - | |
Jerry E. Corbin | M | 64 | - | |
Barry Mark Heck | M | 61 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 13 Jahre |
Todd Simpson | M | 63 | - | |
Rob B. Rogers | M | - | - | |
Roger G. H. Downer | M | 81 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 Jahre |
David C. McDowell | M | 68 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 Jahre |
Kevin Breeden | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 66 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David Holtz
- Persönliches Netzwerk